OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional role of circular RNAs in cancer development and progression
Wei Lun Ng, Taznim Begam Mohd Mohidin, Kirti Shukla
RNA Biology (2018), pp. 1-11
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer
Xiaying Zheng, Mengge Huang, Lei Xing, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 350

Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
Pengfei Zhang, Xu Pei, Kesang Li, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 208

Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
Yang Feng, Anpei Hu, Dan Li, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 190

P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators
Yang Guo, Milad Ashrafizadeh, Murtaza M. Tambuwala, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104161-104161
Closed Access | Times Cited: 21

Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway
Shuang Wang, Lu Liu, X. M. Li, et al.
Neoplasma (2018) Vol. 66, Iss. 02, pp. 232-239
Open Access | Times Cited: 97

The regulation of protein translation and its implications for cancer
Ping Song, Fan Yang, Hongchuan Jin, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 90

Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia
Enrico Gaffo, Elena Boldrin, Anna Dal Molin, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 81

Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498
Yuan Wang, Ying Li, Hangyong He, et al.
Gene (2019) Vol. 720, pp. 144099-144099
Closed Access | Times Cited: 78

hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3
Xuehui Wang, Minghui Chen, Lin Fang
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 122-134
Open Access | Times Cited: 72

Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
Mingyao Huang, Xin Huang, Ning Huang
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1968-1983
Open Access | Times Cited: 63

Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Jun Cao, Mengdi Zhang, Bin Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58

RNMFLP: Predicting circRNA–disease associations based on robust nonnegative matrix factorization and label propagation
Peng Li, Yang Cheng, Huang Li, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 56

CircSEMA4B inhibits the progression of breast cancer by encoding a novel protein SEMA4B-211aa and regulating AKT phosphorylation
Xuehui Wang, Wei Jian, Qifeng Luo, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 49

Biological role and regulation of circular RNA as an emerging biomarker and potential therapeutic target for cancer
Ayman Saleem, Muhammad Umer Khan, Tazeen Zahid, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 13

LGCDA: Predicting CircRNA-Disease Association Based on Fusion of Local and Global Features
Wei Lan, Chunling Li, Qingfeng Chen, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2024) Vol. 21, Iss. 5, pp. 1413-1422
Closed Access | Times Cited: 12

A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine
R.A. Youness, Hossam A. Hassan, Tasneem Abaza, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1245-1245
Open Access | Times Cited: 9

Advanced technological tools to study multidrug resistance in cancer
Andrei Luca, Sandor Kasas, Ignacio Ochoa Garrido, et al.
Drug Resistance Updates (2019) Vol. 48, pp. 100658-100658
Open Access | Times Cited: 66

Circular RNA circ-ADD3 inhibits hepatocellular carcinoma metastasis through facilitating EZH2 degradation via CDK1-mediated ubiquitination.
Suofeng Sun, Wei Wang, Xiaoying Luo, et al.
PubMed (2019) Vol. 9, Iss. 8, pp. 1695-1707
Closed Access | Times Cited: 66

CircRNA has_circ_0078710 acts as the sponge of microRNA-31 involved in hepatocellular carcinoma progression
Binhui Xie, Zhenxian Zhao, Qingquan Liu, et al.
Gene (2018) Vol. 683, pp. 253-261
Closed Access | Times Cited: 59

Page 1 - Next Page

Scroll to top